1. Home
  2. CLST vs XLO Comparison

CLST vs XLO Comparison

Compare CLST & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catalyst Bancorp Inc.

CLST

Catalyst Bancorp Inc.

HOLD

Current Price

$17.06

Market Cap

67.3M

Sector

N/A

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$9.11

Market Cap

56.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLST
XLO
Founded
1922
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.3M
56.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CLST
XLO
Price
$17.06
$9.11
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
2.5K
35.6K
Earning Date
04-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
171.79
N/A
EPS
0.15
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$168.77
P/E Ratio
$111.67
N/A
Revenue Growth
N/A
589.88
52 Week Low
$12.40
$0.46
52 Week High
$18.16
$9.89

Technical Indicators

Market Signals
Indicator
CLST
XLO
Relative Strength Index (RSI) 51.84 52.87
Support Level $16.37 $8.31
Resistance Level $17.19 $9.89
Average True Range (ATR) 0.18 0.39
MACD -0.04 -0.00
Stochastic Oscillator 32.73 69.35

Price Performance

Historical Comparison
CLST
XLO

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It operates in one reportable segment, which generates income principally from interest on loans and investment securities, as well as from fees charged in connection with various loan and deposit services.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: